Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
PhaseV says its causal model predicted weight changes, adverse events and treatment dropout among patients taking GLP-1 and related incretin medications.
OPRA 26.2 adds an AI agent that analyzes clinical trial protocols and drafts risk assessments for human review.
OpenEvidence and Johns Hopkins Medicine will develop an AI focused medical education model and clinical tools that combine research evidence with patient histories.
Stryker plans to invest about $400 million in CMR Surgical and become the exclusive U.S. sales agent for its Versius surgical robot portfolio.
Suvoda is making its Sofia AI assistant, which can take authorized system actions with an audit trail, available for all new trials using its RTSM/IRT or eCOA products.
HealthpointCapital has made a significant investment in Ospitek, which provides AI software for surgical operations and patient flow. Financial terms were not disclosed.
Stephen Harrison will direct Prologue Medicines' scientific strategy and the development of its DELVE machine learning platform and drug pipeline.
A symplr survey found that 40% to 46% of healthcare professionals consider core hospital processes fully manual, while respondents spend an average of 86 minutes each day on administrative tasks they believe AI could reduce.
MediRoutes launched a predictive arrival time feature that uses GPS trip history, machine learning and live traffic data to help medical transport providers build schedules.
Medsender launched software that processes incoming referrals, contacts patients and adds booked appointments to electronic health records.
Sensydia secured more than $6 million to complete a clinical study of its Cardiac Performance System and prepare for a commercial launch.
Red Queen Bio appointed Ian Watson as chief government affairs officer to lead its federal engagement strategy. Watson previously held senior biodefense and biosecurity roles across several US agencies.
TRIAL.OS provides AI assisted applications for clinical trial analysis, risk identification and recommended actions.
ADLM will hold a congressional briefing on October 13 about oversight and regulation for AI used in healthcare and laboratory medicine.
US users will be able to share Function lab results with the Google Health app later this fall, combining biomarker data with wearable metrics and AI coaching.
DeepSight Technology appointed former Volcano and Verb Surgical CEO Scott Huennekens to its board following the completion of a Series C financing.
Flo Health and Google Health will connect cycle insights with wearable data and develop AI models for women's health under a multi year partnership.
Immorta Bio completed planned preclinical studies of SenoMune-0257, a nine amino acid peptide designed to help the immune system eliminate senescent cells. The company plans initial human testing before the end of 2026.
POMDOCTOR plans to combine AI, wearable devices, remote patient monitoring and healthcare data with its physician network and existing services.
Lunit and Discovery Life Sciences will combine AI pathology with biospecimen and laboratory services for biomarker research and drug development.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
